Arcus Biosciences, Inc. (RCUS)
29.21
-1.38
(-4.51%)
USD |
NYSE |
Aug 28, 16:00
29.18
-0.03
(-0.10%)
Pre-Market: 20:00
Arcus Biosciences Total Assets (Quarterly) : 924.00M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 924.00M |
| March 31, 2026 | 997.00M |
| December 31, 2025 | 1.564B |
| September 30, 2025 | 974.00M |
| June 30, 2025 | 1.075B |
| March 31, 2025 | 1.156B |
| December 31, 2024 | 1.15B |
| September 30, 2024 | 1.252B |
| June 30, 2024 | 1.186B |
| March 31, 2024 | 1.293B |
| December 31, 2023 | 1.095B |
| September 30, 2023 | 1.191B |
| June 30, 2023 | 1.22B |
| March 31, 2023 | 1.254B |
| December 31, 2022 | 1.345B |
| September 30, 2022 | 1.394B |
| June 30, 2022 | 1.477B |
| March 31, 2022 | 1.543B |
| Date | Value |
|---|---|
| December 31, 2021 | 1.592B |
| September 30, 2021 | 839.29M |
| June 30, 2021 | 898.77M |
| March 31, 2021 | 935.12M |
| December 31, 2020 | 772.29M |
| September 30, 2020 | 811.08M |
| June 30, 2020 | 481.39M |
| March 31, 2020 | 176.14M |
| December 31, 2019 | 203.11M |
| September 30, 2019 | 216.96M |
| June 30, 2019 | 238.97M |
| March 31, 2019 | 258.53M |
| December 31, 2018 | 274.92M |
| September 30, 2018 | 286.72M |
| June 30, 2018 | 293.86M |
| March 31, 2018 | 305.40M |
| December 31, 2017 | 190.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 2.577B |
| AVITA Medical, Inc. | 47.78M |
| Iovance Biotherapeutics, Inc. | 915.53M |
| Editas Medicine, Inc. | 237.36M |
| Recursion Pharmaceuticals, Inc. | 1.213B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 460.00M |
| Shareholders Equity (Quarterly) | 464.00M |
| Debt to Equity Ratio | 0.2457 |
| Current Ratio | 3.818 |
| Net Debt Paydown Yield | -0.28% |